<b>Health insurance; requirements for certain opioid antagonists.</b> Requires each health insurer, corporation providing health care subscription plans, and health maintenance organization whose policy, contract, or plan includes coverage for prescription drugs to include coverage for at least one opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary. The bill provides that such coverage shall be exempt from any prior authorization or step therapy requirement on coverage of benefits. As introduced, this bill was a recommendation of the Joint Commission on Health Care. This bill is identical to HB 795.
Raw source record
{
"id": 84917,
"url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/sb257\/",
"tags": {
"144309": "health",
"144310": "insurance",
"144311": "medicine",
"144312": "opioids"
},
"text": [
{
"date": "2026-01-12",
"number": "SB257",
"pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/sb257.pdf"
},
{
"date": "2026-02-03",
"number": "SB257S1"
},
{
"date": "2026-02-27",
"number": "SB257H1"
},
{
"date": "2026-03-09",
"number": "SB257H2"
},
{
"date": "2026-03-30",
"number": "SB257ER"
},
{
"date": "2026-04-08",
"number": "CHAP0424"
}
],
"type": "bill",
"year": 2026,
"video": null,
"number": "sb257",
"patron": "Favola, Barbara",
"status": "signed by governor",
"chamber": "senate",
"changes": null,
"outcome": "passed",
"related": [
{
"id": 84633,
"name": "Appropriations",
"year": 2026,
"count": 4,
"number": "hb795",
"status": "signed by governor",
"catch_line": "Health insurance; requirements for certain opioid antagonists.",
"date_introduced": "January 13, 2026"
},
{
"id": 84216,
"name": "Appropriations",
"year": 2026,
"count": 2,
"number": "hb392",
"status": "signed by governor",
"catch_line": "Sickle cell disease education and screening program; cancer risk.",
"date_introduced": "January 12, 2026"
},
{
"id": 84372,
"name": null,
"year": 2026,
"count": 2,
"number": "hb542",
"status": "failed committee",
"catch_line": "Abortion; informed written consent, newborn safety devices.",
"date_introduced": "January 13, 2026"
},
{
"id": 83566,
"name": "Finance",
"year": 2026,
"count": 2,
"number": "sb2",
"status": "signed by governor",
"catch_line": "Paid family & med. leave insurance program; definitions, notice requirements, civil action, report.",
"date_introduced": "November 17, 2025"
},
{
"id": 84856,
"name": "Finance",
"year": 2026,
"count": 2,
"number": "hb1007",
"status": "signed by governor",
"catch_line": "Virginia Birth-Related Neurological Injury Compensation Program and Fund; filing of claims.",
"date_introduced": "January 14, 2026"
}
],
"summary": "<b>Health insurance; requirements for certain opioid antagonists.<\/b> Requires each health insurer, corporation providing health care subscription plans, and health maintenance organization whose policy, contract, or plan includes coverage for prescription drugs to include coverage for at least one opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary. The bill provides that such coverage shall be exempt from any prior authorization or step therapy requirement on coverage of benefits. As introduced, this bill was a recommendation of the Joint Commission on Health Care. This bill is identical to HB 795.",
"version": "CHAP0424",
"copatron": [
{
"shortname": "ksrinivasan",
"partisanship": 26,
"name_formatted": "Sen. Kannan Srinivasan (D-Loudoun)"
}
],
"committee": "Finance",
"full_text": "<p class=\"ldtitle\">An Act to amend the Code of Virginia by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.18:1\/'>38.2-3407.18:1<\/a>, relating to health insurance; requirements for certain opioid antagonists.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That the Code of Virginia is amended by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.18:1\/'>38.2-3407.18:1<\/a> as follows:<\/p><p class=\"catchln\"><em class=\"new\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.18:1\/'>38.2-3407.18:1<\/a>. Requirements for certain opioid antagonists.<\/ins><\/p><p class=\"section\"><em class=\"new\">A. Notwithstanding the provisions of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3419\/'>38.2-3419<\/a>, subdivision A 1 of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-6506\/'>38.2-6506<\/a>, or any other provision of law, each insurer proposing to issue individual or group accident and sickness insurance policies providing hospital, medical, and surgical or major medical coverage on an expense-incurred basis; each corporation providing individual or group accident and sickness subscription contracts; and each health maintenance organization providing a health care plan for health care services whose policy, contract, or plan, including any certificate or evidence of coverage issued in connection with such policy, contract, or plan, shall include coverage for at least one opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and shall ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. No insurer, corporation, or health maintenance organization shall impose any prior authorization or step therapy requirement on coverage of benefits provided pursuant to this section.<\/ins><\/p><p class=\"section\"><em class=\"new\">C. The provisions of this section shall not apply to short-term travel, accident-only, limited or specified disease policies, or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans or to short-term nonrenewable policies of not more than six months' duration.<\/ins><\/p><p class=\"enactcls\">2. That the provisions of this act shall apply to any individual or group accident and sickness insurance policy, individual or group accident and sickness subscription contract, or health care plan for health care services delivered, issued for delivery, or renewed in the Commonwealth on and after January 1, 2027.<\/p><p class=\"enactcls\">3. That to the extent the health benefit or any portion thereof described in <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.18:1\/'>38.2-3407.18:1<\/a> of the Code of Virginia, as created by this act, is included in the Commonwealth's current essential health benefits benchmark plan, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/30-343.1\/'>30-343.1<\/a> of the Code of Virginia, the mandate to provide coverage of such health benefit or portion of the health benefit shall not apply to the individual and small group markets.<\/p>",
"catch_line": "Health insurance; requirements for certain opioid antagonists.",
"duplicates": null,
"session_id": 32,
"word_count": 532,
"patron_party": "D",
"patron_place": "Arlington",
"summary_hash": "4560d6bb06cd690d35c0e2898c79991a",
"patron_prefix": "Sen.",
"patron_suffix": "(D-Arlington)",
"status_detail": "signed by governor",
"_rsun_versions": [
{
"id": "03f57a41897be6dd9c5a237568f18867ce175e11486549f6717c35fb39ea9be2",
"code": "CHAP0424",
"bill_id": 84917,
"source_url": null,
"source_date": "2026-04-08",
"source_hash": "c511273a6f22bda9ce7e0743670a95229b06895ce8828e3ee130d82509dbb952",
"source_html": "<p class=\"ldtitle\">An Act to amend the Code of Virginia by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.18:1\/'>38.2-3407.18:1<\/a>, relating to health insurance; requirements for certain opioid antagonists.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That the Code of Virginia is amended by adding a section numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.18:1\/'>38.2-3407.18:1<\/a> as follows:<\/p><p class=\"catchln\"><em class=\"new\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.18:1\/'>38.2-3407.18:1<\/a>. Requirements for certain opioid antagonists.<\/ins><\/p><p class=\"section\"><em class=\"new\">A. Notwithstanding the provisions of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3419\/'>38.2-3419<\/a>, subdivision A 1 of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-6506\/'>38.2-6506<\/a>, or any other provision of law, each insurer proposing to issue individual or group accident and sickness insurance policies providing hospital, medical, and surgical or major medical coverage on an expense-incurred basis; each corporation providing individual or group accident and sickness subscription contracts; and each health maintenance organization providing a health care plan for health care services whose policy, contract, or plan, including any certificate or evidence of coverage issued in connection with such policy, contract, or plan, shall include coverage for at least one opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and shall ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary.<\/ins><\/p><p class=\"section\"><em class=\"new\">B. No insurer, corporation, or health maintenance organization shall impose any prior authorization or step therapy requirement on coverage of benefits provided pursuant to this section.<\/ins><\/p><p class=\"section\"><em class=\"new\">C. The provisions of this section shall not apply to short-term travel, accident-only, limited or specified disease policies, or contracts designed for issuance to persons eligible for coverage under Title XVIII of the Social Security Act, known as Medicare, or any other similar coverage under state or federal governmental plans or to short-term nonrenewable policies of not more than six months' duration.<\/ins><\/p><p class=\"enactcls\">2. That the provisions of this act shall apply to any individual or group accident and sickness insurance policy, individual or group accident and sickness subscription contract, or health care plan for health care services delivered, issued for delivery, or renewed in the Commonwealth on and after January 1, 2027.<\/p><p class=\"enactcls\">3. That to the extent the health benefit or any portion thereof described in <a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.18:1\/'>38.2-3407.18:1<\/a> of the Code of Virginia, as created by this act, is included in the Commonwealth's current essential health benefits benchmark plan, as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/30-343.1\/'>30-343.1<\/a> of the Code of Virginia, the mandate to provide coverage of such health benefit or portion of the health benefit shall not apply to the individual and small group markets.<\/p>",
"source_metadata": {
"bodyAssociation": "archive-reported-current-version",
"archiveReference": {
"date": "2026-04-08",
"number": "CHAP0424"
}
}
}
],
"copatron_count": 1,
"patron_address": [
"P.O. Box 687",
"Arlington",
"VA 22216"
],
"patron_chamber": "senate",
"patron_started": 2012,
"session_lis_id": 261,
"status_history": [
{
"date": "04\/08\/2026",
"status": "Acts of Assembly Chapter text (CHAP0424)",
"date_raw": "2026-04-08",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "04\/08\/2026",
"status": "Approved by Governor-Chapter 424 (effective 7\/1\/2026)",
"date_raw": "2026-04-08",
"vote_count": null,
"lis_vote_id": null,
"translation": "signed by governor"
},
{
"date": "04\/01\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (SB257)",
"date_raw": "2026-04-01",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/31\/2026",
"status": "Signed by Speaker",
"date_raw": "2026-03-31",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/31\/2026",
"status": "Governor's Action Deadline 11:59 p.m., April 13, 2026",
"date_raw": "2026-03-31",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/31\/2026",
"status": "Enrolled Bill communicated to Governor on March 31, 2026",
"date_raw": "2026-03-31",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/30\/2026",
"status": "Signed by President",
"date_raw": "2026-03-30",
"vote_count": null,
"lis_vote_id": null,
"translation": "passed"
},
{
"date": "03\/30\/2026",
"status": "Bill text as passed Senate and House (SB257ER)",
"date_raw": "2026-03-30",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/30\/2026",
"status": "Enrolled",
"date_raw": "2026-03-30",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/12\/2026",
"status": "House substitute agreed to by Senate (39-Y 1-N 0-A)",
"date_raw": "2026-03-12",
"vote_count": null,
"lis_vote_id": "301928",
"translation": null
},
{
"date": "03\/12\/2026",
"status": "Passed House with substitute Block Vote (96-Y 0-N 0-A)",
"date_raw": "2026-03-12",
"vote_count": null,
"lis_vote_id": "301861",
"translation": "passed house"
},
{
"date": "03\/12\/2026",
"status": "Engrossed by House - committee substitute",
"date_raw": "2026-03-12",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/12\/2026",
"status": "committee substitute agreed to",
"date_raw": "2026-03-12",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/12\/2026",
"status": "committee substitute rejected",
"date_raw": "2026-03-12",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/12\/2026",
"status": "Read third time",
"date_raw": "2026-03-12",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/11\/2026",
"status": "Read second time",
"date_raw": "2026-03-11",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/10\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (SB257)",
"date_raw": "2026-03-10",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/09\/2026",
"status": "Committee substitute printed 26109143D-H2",
"date_raw": "2026-03-09",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/09\/2026",
"status": "Reported from Appropriations with substitute (22-Y 0-N)",
"date_raw": "2026-03-09",
"vote_count": null,
"lis_vote_id": "301168",
"translation": "passed committee"
},
{
"date": "03\/09\/2026",
"status": "Reported from Appropriations with substitute",
"date_raw": "2026-03-09",
"vote_count": null,
"lis_vote_id": "301168",
"translation": "passed committee"
},
{
"date": "03\/05\/2026",
"status": "House committee offered",
"date_raw": "2026-03-05",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "03\/04\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (SB257)",
"date_raw": "2026-03-04",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/27\/2026",
"status": "Committee substitute printed 26108572D-H1",
"date_raw": "2026-02-27",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/27\/2026",
"status": "Assigned HAPP sub: Health & Human Resources",
"date_raw": "2026-02-27",
"vote_count": null,
"lis_vote_id": null,
"translation": "in subcommittee"
},
{
"date": "02\/26\/2026",
"status": "Reported from Labor and Commerce with substitute and referred to Appropriations (21-Y 0-N)",
"date_raw": "2026-02-26",
"vote_count": null,
"lis_vote_id": "299351",
"translation": "passed committee"
},
{
"date": "02\/26\/2026",
"status": "Reported from Labor and Commerce with substitute",
"date_raw": "2026-02-26",
"vote_count": null,
"lis_vote_id": "299351",
"translation": "passed committee"
},
{
"date": "02\/24\/2026",
"status": "Subcommittee recommends reporting with substitute and referring to Appropriations (6-Y 0-N)",
"date_raw": "2026-02-24",
"vote_count": null,
"lis_vote_id": "298801",
"translation": "passed subcommittee"
},
{
"date": "02\/24\/2026",
"status": "Subcommittee recommends reporting with substitute",
"date_raw": "2026-02-24",
"vote_count": null,
"lis_vote_id": "298801",
"translation": "passed subcommittee"
},
{
"date": "02\/24\/2026",
"status": "Assigned HCL sub: Subcommittee #1",
"date_raw": "2026-02-24",
"vote_count": null,
"lis_vote_id": null,
"translation": "in subcommittee"
},
{
"date": "02\/24\/2026",
"status": "House subcommittee offered",
"date_raw": "2026-02-24",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/19\/2026",
"status": "Referred to Committee on Labor and Commerce",
"date_raw": "2026-02-19",
"vote_count": null,
"lis_vote_id": null,
"translation": "in committee"
},
{
"date": "02\/19\/2026",
"status": "Read first time",
"date_raw": "2026-02-19",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/19\/2026",
"status": "Placed on Calendar",
"date_raw": "2026-02-19",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/16\/2026",
"status": "Read third time and passed Senate (37-Y 1-N 0-A)",
"date_raw": "2026-02-16",
"vote_count": null,
"lis_vote_id": "297561",
"translation": "passed senate"
},
{
"date": "02\/13\/2026",
"status": "Engrossed by Senate - committee substitute (Voice Vote)",
"date_raw": "2026-02-13",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/13\/2026",
"status": "Engrossed by Senate (Voice Vote)",
"date_raw": "2026-02-13",
"vote_count": null,
"lis_vote_id": "297284",
"translation": null
},
{
"date": "02\/13\/2026",
"status": "Committee substitute agreed to (Voice Vote)",
"date_raw": "2026-02-13",
"vote_count": null,
"lis_vote_id": "297283",
"translation": null
},
{
"date": "02\/13\/2026",
"status": "Read second time",
"date_raw": "2026-02-13",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/12\/2026",
"status": "Passed by for the day",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/12\/2026",
"status": "Passed by for the day Block Vote (Voice Vote)",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": "296922",
"translation": null
},
{
"date": "02\/12\/2026",
"status": "Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": "296921",
"translation": null
},
{
"date": "02\/12\/2026",
"status": "Rules suspended",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/11\/2026",
"status": "Reported from Finance and Appropriations (15-Y 0-N)",
"date_raw": "2026-02-11",
"vote_count": null,
"lis_vote_id": "296224",
"translation": "passed committee"
},
{
"date": "02\/11\/2026",
"status": "Reported from Finance and Appropriations",
"date_raw": "2026-02-11",
"vote_count": null,
"lis_vote_id": null,
"translation": "passed committee"
},
{
"date": "02\/04\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (SB257)",
"date_raw": "2026-02-04",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/03\/2026",
"status": "Committee substitute printed 26106753D-S1",
"date_raw": "2026-02-03",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/02\/2026",
"status": "Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (10-Y 2-N 1-A)",
"date_raw": "2026-02-02",
"vote_count": null,
"lis_vote_id": "293840",
"translation": "passed committee"
},
{
"date": "02\/02\/2026",
"status": "Senate committee offered",
"date_raw": "2026-02-02",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "01\/23\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (SB257)",
"date_raw": "2026-01-23",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "01\/12\/2026",
"status": "Referred to Committee on Commerce and Labor",
"date_raw": "2026-01-12",
"vote_count": null,
"lis_vote_id": null,
"translation": "in committee"
},
{
"date": "01\/12\/2026",
"status": "Prefiled and ordered printed; Offered 01-14-2026 26104746D",
"date_raw": "2026-01-12",
"vote_count": null,
"lis_vote_id": null,
"translation": "introduced"
}
],
"chief_patron_id": 376,
"date_introduced": "2026-01-12",
"patron_district": 40,
"patron_shortname": "bafavola",
"committee_chamber": "senate",
"status_detail_date": "04\/08\/2026",
"committee_shortname": "finance",
"patron_name_formatted": "Sen. Barbara Favola (D-Arlington)"
}